Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
10 - 31 Mar 1999
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2000
Report date:
2000

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Version / remarks:
adopted 24 Feb 1987
Deviations:
no
GLP compliance:
yes
Remarks:
according to Japanese GLP standard (as described on JECDB)
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2-chlorophenol
EC Number:
202-433-2
EC Name:
2-chlorophenol
Cas Number:
95-57-8
Molecular formula:
C6H5ClO
IUPAC Name:
2-chlorophenol
Test material form:
liquid
Specific details on test material used for the study:
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: in a closed bottle at room temperature
- Stability under test conditions: stable
- Solubility and stability of the test substance in the solvent/vehicle: water solubility is 2.71%, easy soluble in acetone and DMSO

TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Final dilution of a dissolved solid, stock liquid or gel: dilution in olive oil

Test animals

Species:
rat
Strain:
Crj: CD(SD)
Remarks:
Crj:CD(SD)IGS
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Laboratories Japan, Inc., Yokohama, Japan
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 5 weeks
- Weight at study initiation: 128 - 139 g (males), 108 - 120 g (females)
- Fasting period before study: 18 h prior to administration until 3 h after administration
- Housing: 5 animals of the same sex per cage
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 6 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 - 26
- Humidity (%): 45 - 63
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
olive oil
Details on oral exposure:
VEHICLE
- Amount of vehicle: 10 mL/kg bw
- Lot/batch no. (if required): 8123

MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose:
In a pre-test, doses of 250, 500 and 1000 mg/kg bw was administered to 3 males and females. No mortality occured during the 7 day observation period. Based on this result, the main study was performed at 500, 1000 and 2000 mg/kg bw.
Doses:
500, 1000 and 2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
yes
Remarks:
gavage with olive oil
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed 5 times at the first day and daily thereafter. Individual weights were determined on Day 0 prior to administration and at Day 4, 8 and 15.
- Necropsy of survivors performed: yes

Results and discussion

Preliminary study:
Doses of 250, 500 and 1000 mg/kg bw were administered to 3 males and females. A control group was included. No death occurred during the following observation period (7 days). Locomotor activity was decreased in the high-dose group at the first day. According to this result, doses of 500, 1000 and 2000 mg/kg bw were applied in the main study.
Effect levelsopen allclose all
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
> 1 000 - < 2 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: no male died at 1000 mg/kg bw; 3/5 males died at 2000 mg/kg bw
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: 2/5 females died at 2000 mg/kg bw
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
2 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: combined approach: 5/10 animals died at 2000 mg/kg bw
Mortality:
500 mg/kg bw: 0/5 males and 0/5 females died
1000 mg/kg bw: 0/5 males and 0/5 females died
2000 mg/kg bw: 3/5 males and 2/5 females
Clinical signs:
500 and 1000 mg/kg bw: decreased locomotor activity, abnormal gait, clonic convulsion and lateral or prone position in males; decreased locomotor activity, abnormal gait and clonic convulsion in femals
2000 mg/kg bw: decreased locomotor activity and abnormal gait in males; abnormal gait in femals

all dose groups, non-surviving animals: decreased locomotor activity, clonic convulsion, lateral or prone position 15 minutes after administration
Body weight:
500 and 1000 mg/kg bw: body weight gains were within the normal ranges in males and females during the whole study period
2000 mg/kg bw: slightly decreased body weight gains observed in surviving animals at Day 4
Gross pathology:
500 and 1000 mg/kg bw: no abnormal findings
2000 mg/kg bw:
- non-survivng animals: discoloration in spleen was found in 1/2 female
- surviving animals sacrificed at termination: no abnormal findings

Any other information on results incl. tables

Table 1. Summary of results

Dose
[mg/kg bw]

Toxicological results*

Duration of clinical signs

Time of death

Mortality (%)

Males

Control

0/0/5

---

---

---

500

0/4/5

15 min – 3 h

---

0

1000

0/4/5

15 min – 3h

---

0

2000

3/5/5

15 min – day 4 (surviving)

1 – 3 h

60

Females

 Control

0/0/5

---

---

---

500

0/3/5

15 min – 1 h

---

0

1000

0/5/5

15 min – 1 h

---

0

2000

2/5/5

15 min – day 3 (surviving)

1 h – day 2

40

LD50 = 2000 mg/kg bw

* first number = number of dead animals

second number = number of animals with clinical signs

third number = number of animals used

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
CLP: Acute toxicity, Cat. 4, H302